StockNews.com initiated coverage on shares of VBI Vaccines (NASDAQ:VBIV – Free Report) in a research note released on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. VBI Vaccines Stock Performance Shares of VBI Vaccines stock opened at $0.60 on Monday. VBI Vaccines has a one year low of $0.45 and […]